ARTICLE | Clinical News
BIO-11006 Inhalation Solution: Phase I data
February 11, 2008 8:00 AM UTC
In a double-blind, placebo-controlled Phase I trial (BIM-CL-001) in 8 volunteers, single doses of BIO-11006 were safe and well tolerated. The company plans to begin a Phase II trial in COPD patients w...